Top Biotechnology companies in Denmark by Total Liabilities

This ranking features the top 17 Biotechnology companies in Denmark ranked by Total Liabilities, totaling a Total Liabilities of USD 52.63 B, for July 25, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue Revenue Year-on-Year (YoY) growth Operating Income EBIT EBITDA Free Cash Flow Dividend Yield Free Cash Flow Yield Total Assets Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

Frequently Asked Questions

Which Biotechnology company in Denmark has the highest Total Liabilities ?

The Biotechnology company in Denmark with the highest Total Liabilities is Novo Nordisk A/S (Copenhagen Stock Exchange: NOVO-B.CO) at USD 44.61 B.

Which Biotechnology company in Denmark has the lowest Total Liabilities ?

The Biotechnology company in Denmark with the lowest Total Liabilities is ViroGates A/S (Copenhagen Stock Exchange: VIRO.CO) at None.

What are the top 10 Biotechnology companies in Denmark by Total Liabilities ?

The top 10 Biotechnology companies in Denmark by Total Liabilities are Novo Nordisk A/S, H. Lundbeck A/S, Ascendis Pharma A/S, Genmab A/S, Bavarian Nordic A/S, ALK-Abelló A/S, Zealand Pharma A/S, Gubra A/S, ChemoMetec A/S and Evaxion Biotech A/S.

What are the bottom 10 Biotechnology companies in Denmark by Total Liabilities ?

The bottom 10 Biotechnology companies in Denmark by Total Liabilities are ViroGates A/S, IO Biotech, Inc., Initiator Pharma A/S, FluoGuide A/S, 2cureX AB (publ), BioPorto A/S, Saniona AB (publ), Evaxion Biotech A/S, ChemoMetec A/S and Gubra A/S.